Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
The study will have blood pressure measurements, physical exams, blood draws, urine collection including 24 hour urine collection, quality of life surveys and study drug/placebo intravenous infusion. You will also need to be vaccinated against some specific diseases.
information provided upon request, mileage reimbursement
Clinical and Translational Research Center (CTRC)
Burnett-Womack Building (UNC-Chapel Hill)
160 Dental Cir, Chapel Hill, NC 27514, USA
Clinical or Medical
Kidneys and Liver
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.